SGMT
Sagimet Biosciences Inc. Series A
9.20$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Sagimet Biosciences Inc. Series A (SGMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.9 | -7.1 | -6.2 | -5.6 | -20 | -11 | -15 | -9.1 | -10 | -12 | -8.6 | -11 | -41 | |
| 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.9 | 1.3 | 0.8 | 1.4 | 1.5 | 1.5 | 1.5 | 1.6 | 1.7 | 1.7 | 1.8 | 3.7 | 8.9 | |
| 0.6 | -0.3 | -0.2 | 1.5 | -0.2 | 3.7 | -0.7 | -0.1 | 0.7 | -4.3 | 0.3 | 0.1 | -3.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | -20 | 3.0 | -75 | 0.6 | 9.9 | 3.4 | -13 | 0.1 | 14 | 10 | -24 | 0.6 | |
| 87 | 3.5 | 105 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | – | 339 | – | |
| 83 | -27 | 102 | -81 | -19 | -1.2 | -11 | -22 | -9.8 | 2.5 | 1.6 | 305 | 299 | |
| -3.9 | -7.1 | -6.2 | -5.6 | -20 | -11 | -15 | -9.1 | -10 | -12 | -8.6 | -11 | -41 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.